研报新知|治疗白癜风的首款处方药即将获批,这家药企值得关注

界面
18 Oct 2024

中国约有1400万白癜风患者,存在巨大的未满足临床需求。全球仅有芦可替尼乳膏获批用于白癜风的治疗,成药性明确。该药物于2024年9月在国内递交了上市申请并已获受理,有望成为首个在中国上市的白癜风治疗处方药。芦可替尼乳膏的成功上市将填补国内白癜风治疗领域的空白。国内开发这款药的正是这家公司。公司拥有三十多款以First-in-Class(FIC)和Best-in-Class(BIC)为主的创新产品,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10